Clinical Trial

Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

Study acronym: ACS_ATHEROLIV
Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated December 9, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
the study aims to examine the short-term (30 days) effects of olive leaf extract on endothelial function in patients with acute coronary syndrome (ACS). This investigation will be conducted on patients admitted to the emergency department for ACS. All participants will be screened and included within 24 hours post-ACS event and prior to discharge from the emergency department.
Trial Details
NCT Number NCT06723002
Lead Sponsor University of Monastir
Conditions Acute Coronary Syndrome (ACS), Reactive Hyperemia, Endothelial Dysfunction
Enrollment 300 participants
Start Date 2024-12-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-09